Sensulin

Sensulin, LLC is an Oklahoma-based company that focuses on developing glucose-responsive insulin for the treatment of type I and type II diabetes. Utilizing its proprietary Agglomerated Vesicle Technology, the company creates a drug delivery platform that employs liposomes linked by a stimulus-responsive molecule. This innovative approach aims to mimic the functionality of a healthy human pancreas, potentially allowing for a true once-a-day insulin solution. Sensulin's insulin formulation seeks to eliminate the necessity for separate basal and prandial insulin, significantly reducing the need for glucose monitoring and multiple daily injections, thereby improving the quality of life for individuals living with diabetes. Established in 2011, Sensulin is dedicated to advancing diabetes care through its groundbreaking research and development efforts.